Pure Global

BIOLABO Total and Direct Bilirubin Sulfanilic Acid Method - Indonesia BPOM Medical Device Registration

BIOLABO Total and Direct Bilirubin Sulfanilic Acid Method is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101816841. The device is manufactured by BIOLABO SAS from France, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is PT. CIPTA VARIA KHARISMA UTAMA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
BIOLABO Total and Direct Bilirubin Sulfanilic Acid Method
Analysis ID: AKL 20101816841

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Manufacturer

BIOLABO SAS

Country of Origin

France

Authorized Representative

PT. CIPTA VARIA KHARISMA UTAMA

AR Address

Jl. Utan Kayu Raya No. 105A Jakarta

Registration Date

Oct 28, 2022

Expiry Date

Apr 19, 2027

Product Type

Clinical Chemistry Test System

Bilirubin (total or direct) test system

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing